ALDOCK
ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer. The company is conducting research and development of risk tests that will help in the early detection of cancer. ALDOCK analyzes biomarker measurement results by machine learning to constantly improve inspection accuracy, and also construct an NGS analysis pipeline for that purpose. It provides a secure API / SDK that can be shared with other applications, as well as the inspection result can be confirmed by the user from the application.
ALDOCK
Industry:
Biotechnology Career Planning Employment Health Care Human Resources Life Science Product Research
Founded:
2016-12-01
Address:
Shinjuku, Yamanashi, Japan
Country:
Japan
Website Url:
http://www.aldock.co.jp
Total Employee:
11+
Status:
Active
Total Funding:
716.57 K USD
Technology used in webpage:
Amazon Google Apps For Business Amazon Route 53 Amazon Tokyo Region
Similar Organizations
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Lifetime Ventures
Lifetime Ventures investment in Seed Round - ALDOCK
Incubate Fund
Incubate Fund investment in Seed Round - ALDOCK
